• Carcinoembryonic Antigen (CEA), Peritoneal Fluid
  • BCR-ABL, Translocation, FISH, Blood
  • Intrinsic Factor Blocking Antibody
  • Burkitt lymphoma
  • Pyogenic arthritis (septic arthritis)
  • Gastric Parietal Cell Antibody, IgG
  • Acute viral encephalitis
  • Complete Autoimmune (Connective Tissue Autoimmune) Disease Panel
  • Dopamine receptor 1 (DRD1) Genotyping
  • UBE3A Gene Mutation Analysis, Angelman Syndrome, Blood
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Clinical Utility
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...